Guardant Health, Inc. Stockholders Equity

Quick Answer

Guardant Health, Inc. reported Stockholders Equity of -$99.31 million for fiscal year 2025.

Guardant Health, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 -$99.31M +28.9%
2024 -$139.65M -188.0%
2023 $158.68M +163.7%
2022 $60.18M -90.7%
2021 $645.00M -50.3%
2020 $1.30B +62.6%
2019 $798.39M +65.2%
2018 $483.15M +56.6%
2017 $308.61M +287.2%
2016 $79.70M -4.5%
2015 $83.44M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$354.47M -489.8% -16.0%
June 30, 2025 -$305.48M -18838.3% -21.8%
March 31, 2025 -$250.79M -467.3% -79.6%
December 31, 2024 -$139.65M -188.0% -132.4%
September 30, 2024 -$60.10M -126.3% -3625.7%
June 30, 2024 -$1.61M -100.6% -102.4%
March 31, 2024 $68.28M +253.3% -57.0%
December 31, 2023 $158.68M +163.7% -30.5%
  • Guardant Health, Inc. showed an increase of +28.9% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2015–2025 period, Guardant Health, Inc.’s stockholders equity has declined by 219.0% (from $83.44 million to -$99.31 million).
  • The most recent figure is from Guardant Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment